`Filed: February 28, 2019
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`___________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`___________________
`
`MYLAN PHARMACEUTICALS INC.,
`TEVA PHARMACEUTICALS USA, INC. and AKORN INC.,1
`Petitioners,
`
`v.
`
`SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC.,
`Patent Owners.
`___________________
`
`Case IPR2016-01127 (US 8,685,930 B2)
`Case IPR2016-01128 (US 8,629,111 B2)
`Case IPR2016-01129 (US 8,642,556 B2)
`Case IPR2016-01130 (US 8,633,162 B2)
`Case IPR2016-01131 (US 8,648,048 B2)
`Case IPR2016-01132 (US 9,248,191 B2)
`___________________
`
`PETITIONER MYLAN PHARMACEUTICALS INC.’S CORRECTED
`MOTION FOR PRO HAC VICE ADMISSION UNDER 37 C.F.R. § 42.10(c)
`
`
`
`1 Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017-
`00596, IPR2017-00579 and IPR2017-00598, IPR2017-00583 and IPR2017-00599,
`IPR2017-00585 and IPR2017-00600, and IPR2017-00586 and IPR2017-00601,
`have respectively been joined with the captioned proceedings. The word-for-word
`identical paper is filed in each proceeding identified in the caption pursuant to the
`Board’s Scheduling Order (Paper 10).
`
`
`
`This paper replaces Paper No. 76 in IPR2016-01127, Paper No. 78 in
`
`IPR2016-01128, and Paper No. 75 in each of IPR Nos. 2016-01129, 2016-01130,
`
`2016-01131, and 2016-01132. Pursuant to 37 C.F.R. § 42.10(c), Petitioner Mylan
`
`Pharmaceuticals Inc. (“Petitioner”) respectfully requests that the Board recognize
`
`(1) Shannon M. Bloodworth, (2) Charles G. Curtis, Jr., (3) Jennifer A. MacLean,
`
`and (4) Benjamin S. Sharp as counsel pro hac vice in this proceeding. Petitioner
`
`seeks the counsel of Shannon Bloodworth due to her experience in pharmaceutical
`
`patent matters. Petitioner seeks the counsel of Charles G. Curtis, Jr., Jennifer A.
`
`MacLean, and Benjamin S. Sharp for their expertise in claims of Tribal sovereign
`
`immunity. This corrected motion is authorized by the Board’s February 28, 2019
`
`email, and by Paper No. 4.
`
`I. STATEMENT OF FACTS
`A. Shannon M. Bloodworth
`
`Ms. Bloodworth is a patent litigation attorney with experience representing
`
`clients in multiple jurisdictions, including United States District Courts and the
`
`Federal Circuit Court of Appeals. Ms. Bloodworth has experience in all stages of
`
`litigation, from preliminary injunction through trial and appeal, and across a wide
`
`range of technologies, including pharmaceutical drugs, formulations, and dosages.
`
`Ms. Bloodworth has previously been admitted pro hac vice to three inter partes
`
`reviews: IPR No. 2015-00643, IPR No. 2015-00644, and IPR No. 2015-00830.
`
`-2-
`
`
`
`B. Charles G. Curtis, Jr.
`
`Mr. Curtis has extensive experience litigating cases involving Indian law in
`
`many different courts across the United States, as well as Federal administrative
`
`boards. He specifically has extensive experience litigating cases involving Indian
`
`law. Many of these cases have involved disputed claims of Tribal sovereign
`
`immunity. He has represented private and public clients in litigation, agency
`
`proceedings, and business negotiations involving Native American tribes, tribal
`
`entities, and tribal members throughout the country, including with respect to the St.
`
`Regis Mohawk (Akwasasne) Tribe. He also has experience in constitutional, treaty
`
`rights, and intellectual property law.
`
`C.
`
`Jennifer A. MacLean
`
`Ms. MacLean has extensive experience litigating cases involving Indian law
`
`in many different courts across the United States, as well as Federal administrative
`
`boards. She has over 16 years of experience litigating Indian law and tribal
`
`sovereign immunity . Her practice focuses on helping State and local governments,
`
`businesses and community groups navigate issues related to Federal Indian law. Her
`
`experience in this area includes aboriginal land claims, treaty disputes, compact
`
`negotiations, Tribal acknowledgment, and Federal preemption questions.
`
`-3-
`
`
`
`D. Benjamin S. Sharp
`
`Mr. Sharp has extensive experience litigating cases involving Indian law in
`
`many different courts across the United States, as well as Federal administrative
`
`boards, specifically including issues of Tribal sovereign immunity.
`
`E. Meet & Confer
`
`Counsel for the Tribe indicated that it did not oppose this motion.
`
`II. DECLARATION OF INDIVIDUAL SEEKING TO APPEAR
`
`This Motion for Pro Hac Vice Admission is accompanied by a Declaration of
`
`Shannon M. Bloodworth (EX1138), a Declaration of Charles G. Curtis, Jr.
`
`(EX1139), a Declaration of Jennifer A. MacLean (EX1140), and a Declaration of
`
`Benjamin S. Sharp (EX1142). In each declaration, the declarant attests to each of
`
`the listed items required by the Order Authorizing Motion for Pro Hac Vice
`
`Admission in Case IPR2013-00639, Paper 7.
`
`III. CONCLUSION
`
`For the foregoing reasons, Petitioner respectfully requests that the Board
`
`admit Shannon M. Bloodworth, Charles G. Curtis, Jr., Jennifer A. MacLean, and
`
`Benjamin S. Sharp as counsel Pro Hac Vice in this proceeding.
`
`Dated: February 28, 2019
`
`
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee, Lead Counsel
` Reg. No. 31,990
`
`
`
`
`
`
`
`
`-4-
`
`
`
`CERTIFICATE OF SERVICE
`This is to certify that I caused to be served true and correct copy of the
`
`foregoing Petitioner Mylan Pharmaceuticals Inc.’s Corrected Motion for Pro Hac
`
`Vice Admission Under 37 C.F.R. § 42.10(c) on this 28th day of February, 2019, on
`
`the Patent Owner at the correspondence address of the Patent Owner as follows:
`
`Dorothy P. Whelan
`Michael Kane
`Susan Morrison Colletti
`Robert M. Oakes
`Jonathan Singer
`FISH & RICHARDSON P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Email: IPR13351-0008IP1@fr.com
`Email: IPR13351-0008IP2@fr.com
`Email: IPR13351-0008IP3@fr.com
`Email: IPR13351-0008IP4@fr.com
`Email: IPR13351-0008IP5@fr.com
`Email: IPR13351-0008IP6@fr.com
`Email: PTABInbound@fr.com
`
`Alfonso Chan
`Joseph DePumpo
`Michael W. Shore
`Christopher L. Evans
`SHORE CHAN DEPUMPO LLP
`901 Main Street, Suite 3300
`Dallas, TX 75201
`Email: achan@shorechan.com
`Email: jdepumpo@shorechan.com
`Email: mshore@shorechan.com
`Email: cevans@shorechan.com
`
`-5-
`
`
`
`Marsha K. Schmidt
`
`Email: marsha@mkschmidtlaw.com
`
`And on the remaining petitioners as follows:
`
`
`Gary Speier
`Mark Schuman
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST & SCHUMAN, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolois, MN 55402
`Email: gspeier@carlsoncaspers.com
`Email: mschuman@carlsoncaspers.com
`Email: IPRCyclosporine@carlsoncaspers.com
`
`Ralph Wilson Powers III
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Avenue, N.W.
`Washignton, D.C. 20005
`Email: tpowers-PTAB@sternekessler.com
`Email: PTAB@sternekessler.com
`Attorneys for Teva Pharmaceuticals USA, Inc.
`
`Michael Dzwonczyk
`Mark Boland
`SUGHRUE MION, PLLC
`2100 Pennsylvania Ave., NW
`Washington, DC 20037
`Email: mdzwonczyk@sughrue.com
`Email: mboland@sughrue.com
`Attorneys for Akorn Inc.
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee, Lead Counsel
`Reg. No. 31,990
`
`
`
`
`
`Dated: February 28, 2019
`
`
`
`
`
`-6-
`
`